EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--April 17, 2006--SurModics, Inc. (Nasdaq:SRDX - News), a leading provider of surface modification and drug delivery technologies to the healthcare industry, today announced that its advanced Hydrophilic Technology has been licensed to Devax, Inc. to provide the lubricious coating on its AXXESS(TM) Biolimus A-9(TM) Eluting Bifurcation Stent delivery system.
